AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 NOV 6 - (NewsRx.com & NewsRx.net) -- In response to the FDA's plan to consolidate reviews of pharmaceutical products, including biologics, at the Center for Drug Evaluation and Research, BIO [Biotechnology Industry Organization] president Carl B. Feldbaum issued the following statement:
"Although the details and their full implications have yet to be determined, we are pleased with the Bush administration's efforts to bring life-saving drugs to patients faster alongside greater consistency in the drug development and review process.
"It is our understanding that therapeutic biologics will continue to be regulated under the Public Health Service Act, ...